Finance

Lists
Why is MRK up 2.26%?
Dive Deeper
MRK:NYSE
Merck & Co Inc
$ 145.60
+2.26%
(+3.22) 1D
$ 146.31
+0.49% (+0.71)
After hours
Closed: 10-р сарын 9, 16:02:34 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
$ 141.37
High
$ 146.68
Low
$ 141.36
Mkt. cap
359.22Т
Avg. vol.
9.40 сая
Volume
9.29 сая
Dividend
2.34%
Quarterly dividend
$ 0.85
Ex-dividend date
2026 оны 9-р сарын 15
P/E ratio
116.29
52-wk high
$ 156.92
52-wk low
$ 82.01
EPS
$ 1.25
Beta
0.21
Shares outstanding
2.47 тэрбум
No. of employees
74 мян
Open
$ 141.37
High
$ 146.68
Low
$ 141.36
Mkt. cap
359.22Т
Avg. vol.
9.40 сая
Volume
9.29 сая
Dividend
2.34%
Quarterly dividend
$ 0.85
Ex-dividend date
2026 оны 9-р сарын 15
P/E ratio
116.29
52-wk high
$ 156.92
52-wk low
$ 82.01
EPS
$ 1.25
Beta
0.21
Shares outstanding
2.47 тэрбум
No. of employees
74 мян
News stories
From web sources and news partners
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74 мян
Founded1891 оны 1-р сарын 1
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Analyst ratings
Based on 21 analysts giving stock ratings to MRK in the past 3 months
Buy
Buy
14
Hold
7
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for MRK in the last 3 months.
Highest
Current $ 145.60
$ 180.00 (+23.63%)
Average
$ 160.38 (+10.15%)
Lowest
$ 105.00 (-27.88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Yee
UBS
Buy
Maintained
$ 175.00
+20.2%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
$ 163.00
+12%
10/09/2026
Evan Seigerman
BMO Capital
Buy
Reiterated
$ 170.00
+16.8%
10/08/2026
Carter Gould
Cantor Fitzgerald
Hold
Reiterated
$ 145.00
-0.4%
10/08/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
$ 177.00
+21.6%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
$ 165.00
+13.3%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
$ 160.00
+9.9%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
$ 180.00
+23.6%
09/29/2026
Geoff Meacham
Citi
Hold
Maintained
$ 125.00
-14.1%
09/29/2026
Trung Huynh
RBC Capital
Hold
Maintained
$ 150.00
+3%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
$ 155.00
+6.5%
09/22/2026
Nico Chen
DBS
Buy
Maintained
$ 180.00
+23.6%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
$ 172.00
+18.1%
09/10/2026
Daina Graybosch
Leerink Partners
Buy
Reiterated
$ 161.00
+10.6%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$ 170.00
+16.8%
09/08/2026
Emily Field
Barclays
Hold
Reiterated
€ 150.00
+3%
09/07/2026
Courtney Breen
Bernstein
Hold
Maintained
$ 105.00
-27.9%
09/07/2026
Mohit Bansal
Wells Fargo
Buy
Reiterated
$ 170.00
+16.8%
09/04/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
$ 170.00
+16.8%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
$ 180.00
+23.6%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
$ 127.00
-12.8%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
$ 138.00
-5.2%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
$ 130.00
-10.7%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
$ 179.00
+22.9%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
$ 150.00
+3%
02/13/2026
Last report
2026 оны 8-р сарын 4
Fiscal period
Q2 2026
-$ 0.13 / -$ 0.26
+49.43%beat
Revenue / Est. (USD)
16.61 тэрбум / 16.37 тэрбум
+1.46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
17.28 тэрбум
16.40 тэрбум
16.29 тэрбум
16.61 тэрбум
Cost of goods sold
3.74 тэрбум
4.30 тэрбум
3.88 тэрбум
4.13 тэрбум
Cost of revenue
3.74 тэрбум
4.30 тэрбум
3.88 тэрбум
4.13 тэрбум
Research and development expenses
4.00 тэрбум
4.00 тэрбум
3.56 тэрбум
9.74 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.48 тэрбум
2.73 тэрбум
2.57 тэрбум
2.78 тэрбум
Operating expense
6.48 тэрбум
6.73 тэрбум
6.12 тэрбум
12.52 тэрбум
Total operating expenses
10.23 тэрбум
11.02 тэрбум
10.00 тэрбум
16.65 тэрбум
Operating income
7.05 тэрбум
5.38 тэрбум
6.29 тэрбум
-40.00 сая
Other non operating income
-
41.00 сая
42.00 сая
59.00 сая
EBT including unusual items
6.74 тэрбум
3.42 тэрбум
-3.53 тэрбум
-683.00 сая
EBT excluding unusual items
6.76 тэрбум
4.98 тэрбум
5.85 тэрбум
-508.00 сая
Income tax expense
958.00 сая
458.00 сая
709.00 сая
654.00 сая
Effective tax rate
14.20%
13.39%
-20.06%
-95.75%
Other operating expenses
-
-
-
-
Net income
5.78 тэрбум
2.96 тэрбум
-4.24 тэрбум
-1.34 тэрбум
Net profit margin
33.49%
18.07%
-26.03%
-8.04%
Earnings per share
2.58
2.04
-1.28
-0.13
Interest and investment income
96.00 сая
69.00 сая
35.00 сая
35.00 сая
Interest expense
-327.00 сая
-411.00 сая
-479.00 сая
-525.00 сая
Net interest expenses
-231.00 сая
-342.00 сая
-444.00 сая
-490.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
8.15 тэрбум
6.79 тэрбум
7.69 тэрбум
1.43 тэрбум
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс